KIOCL on the verge of 8 years BreakOut📊 KIOCL Ltd – 8-Year Breakout Summary
🔑 Price Action Overview
The stock is trading at ₹528.80 (+19.99%), hitting an upper circuit with strong momentum.
Price is on the verge of a multi-year breakout from the consolidation zone that lasted nearly 8 years (2017–2025).
Historically, every breakout in KIOCL has led to sharp parabolic moves (2017 rally, 2020 rally, 2024 rally).
📈 Key Resistance Levels
1. ₹540 – ₹560 zone → Immediate breakout resistance (current price testing this zone).
2. ₹620 – ₹650 → Next major resistance; earlier rejection zones in 2017 and 2024.
3. ₹750 – ₹800 → Medium-term resistance zone.
4. ₹900 – ₹1000 → Psychological & historical supply zone.
📉 Key Support Levels
1. ₹500 – ₹510 → Immediate support (previous resistance now acting as support).
2. ₹450 – ₹460 → Strong support, base of recent rally.
3. ₹400 – ₹410 → Long-term support, multiple touch points (2023–24).
4. ₹340 – ₹350 → Strong multi-year support zone; breakdown here invalidates bullish structure.
🔍 Volume & Strength
Volume has spiked sharply (11.5M vs avg 9.9M), confirming institutional buying interest.
Weekly chart breakout with highest volume in years indicates accumulation phase turning into expansion phase.
📊 Technical Indicators
Momentum: RSI likely entering overbought zone but still bullish (strengthening breakout).
Trend: Higher highs & higher lows visible since mid-2023.
Pattern: Cup & Handle / Long-term Rectangle breakout.
🚀 Upside Potential
Measured move targets (based on breakout projections):
First Target: ₹620 – ₹650 (20–25% upside)
Second Target: ₹750 – ₹800 (45–50% upside)
Final Target: ₹900 – ₹1000 (80–85% upside)
⚠️ Risks
Profit booking after sharp rallies.
If it fails to sustain above ₹500 support, trend may weaken.
PSU stocks can be volatile due to government policies.
✅ Summary in One Line:
KIOCL is on the verge of an 8-year breakout with strong volumes. Sustaining above ₹500–₹510 opens the gates for ₹620 → ₹750 → ₹900+ in the medium to long term, while downside is protected by ₹450 & ₹400 supports.
Superchartz
#SPARC is getting ready for a sparkling move #superchartzKey Levels:
Support: 360 to 350
Resistance: 389, 399, 421
Key Drivers:
Sun Pharma Advanced Research Company Ltd focuses on R&D of pharmaceutical products, earning revenue from license fees, royalties, and R&D services. In FY23, it obtained USFDA approval for Sezaby and filed for NDA of PDP-716 in collaboration with Visiox Pharma. The company primarily targets oncology & neurodegeneration, with 8 pipeline assets in various stages. It has shifted focus from New Drug Delivery Systems to New Chemical Entities, investing heavily in R&D. SPARC is part of the SunPharma Group, with significant corporate backing. It faced an IT security incident in March 2023, though business operations were not directly impacted. The company plans Phase 1 studies for SCD-153 and SBO-154 in FY24 and FY25, respectively, aiming for continued growth through collaborations and new preclinical programs.